L26/O-112 Virtual reality is a feasible, effective, and safe intervention for reducing pain and anxiety during oocyte retrieval: a randomised controlled trial
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.112 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von L. Wang und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does virtual reality intervention effectively reduce pain and anxiety, and is it feasible and safe for patients undergoing oocyte retrieval? Summary answer Virtual reality significantly reduces pain and anxiety during oocyte retrieval and is a feasible and safe adjunctive therapy. What is known already Pharmacological analgesia is standard for pain management during oocyte retrieval but carries risks of side effects. Although virtual reality has shown efficacy in reducing procedural pain and anxiety in other clinical settings, its application and effectiveness in assisted reproduction remain inadequately studied. Study design, size, duration This parallel-group, prospective, randomized controlled trial was conducted at a single reproductive medicine center from June 2022 to July 2023, enrolling 113 participants to assess changes in pain and anxiety. Participants/materials, setting, methods Patients were randomized to a VR group (n = 55), which received preoperative simulation and intraoperative immersive videos, or a standard care control group (n = 58). Primary outcomes were changes in pain and anxiety scores. Main results and the role of chance Pain scores were significantly lower in the VR group than in the control group both during the procedure (median [IQR]: 3 [2-4] vs. 4 [2-5], p < 0.001) and 1 hour postoperatively (2 [1-3] vs. 3 [2-4], p < 0.05). Preoperative anxiety assessed 10 minutes before the procedure was also lower in the VR group (mean [SD]: 37.45 [4.92] vs. 39.89 [5.34]; p < 0.05). Intraoperatively, the VR group demonstrated a lower mean heart rate (85.38 [0.87] vs. 90.62 [13.08] bpm; p < 0.05) and respiratory rate (15.64 [2.70] vs. 19.04 [11.40] breaths/min; p < 0.05). No significant between-group differences were observed in adverse effects or pregnancy rates (all p > 0.05). Limitations, reasons for caution This was a single-center study with a limited sample size, and the long-term efficacy of the intervention was not assessed. Results may not be generalizable to all clinical settings or patient populations. Wider implications of the findings The findings support integrating VR as a patient-centered, non-pharmacological intervention into routine ART workflows to improve patient experience, potentially reduce analgesic reliance, and enhance clinical efficiency. Trial registration number Yes
Zitieren
APA
Wang, L., & Hong, L. (2026). L26/O-112 Virtual reality is a feasible, effective, and safe intervention for reducing pain and anxiety during oocyte retrieval: a randomised controlled trial. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.112
Vancouver
Wang L, Hong L. L26/O-112 Virtual reality is a feasible, effective, and safe intervention for reducing pain and anxiety during oocyte retrieval: a randomised controlled trial. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.112
BibTeX
@article{Wang2026,
author = {Wang, L. and Hong, L.},
title = {L26/O-112 Virtual reality is a feasible, effective, and safe intervention for reducing pain and anxiety during oocyte retrieval: a randomised controlled trial},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.112}
}
EUVIMED